Class Review Schedule

The next D&T Committee meeting will be held September 13, 2017
 

HFS will be reviewing the following classes for the September meeting:

 

Diabetes DPP-4 Inhibitors

 

Diabetes GLP-1 Receptor Agonists

 

Diabetes SGLT2 Inhibitors

 

Diabetes Long Acting Insulin

 

Stimulants/ADHD Agents

 

All clinical and financial submissions for this meeting must be sent to the Department no later than 3pm CST on August 23, 2017.  Any changes to drug status will become effective on or after October 1, 2017.

 

 

 

 

 
 

 


Pharmacy

 

 Need Assistance?